Clinical trials
Borderline Personality Disorder trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2006 | 1 |
| 2009 | 2 |
| 2012 | 4 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 7 |
| 2022 | 8 |
| 2023 | 4 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 49 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 3 |
| Bronx VA Medical Center | 2 |
| Katharina Bachmann | 2 |
| NHS Greater Glasgow and Clyde | 2 |
| Shalvata Mental Health Center | 2 |
| Universitat Jaume I | 2 |
| Arkin | 1 |
| Camille Nemitz Piguet | 1 |
| Centre Hospitalier Universitaire de Besancon | 1 |
| Freie Universität Berlin | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Borderline Personality Disorder | 49 |
| Stress Disorders, Post-Traumatic | 7 |
| Personality Disorders | 3 |
| Anxiety Disorders | 2 |
| Attention Deficit Disorder with Hyperactivity | 2 |
| Bipolar Disorder | 2 |
| Schizophrenia | 2 |
| Adjustment Disorders | 1 |
| Alcoholism | 1 |
| Antisocial Personality Disorder | 1 |
Trials
Showing 76 to 49 of 49. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.